Residency · Sacramento, CA
Sponsored by University of California Davis Health
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.
Genetics in medicine : official journal of the American College of Medical Genetics · 2021 · 627 citations · Katherine Rauen
Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.
Genetics in medicine : official journal of the American College of Medical Genetics · 2022 · 234 citations · Katherine Rauen
Project Baby Bear: Rapid precision care incorporating rWGS in 5 California children's hospitals demonstrates improved clinical outcomes and reduced costs of care.
American journal of human genetics · 2021 · 214 citations · Madelena Martin, Katherine Rauen, Suma Shankar
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.
Neuro-oncology · 2022 · 89 citations · Katherine Rauen
Defining RASopathy.
Disease models & mechanisms · 2022 · 58 citations · Katherine Rauen
Pathogenic variants in KMT2C result in a neurodevelopmental disorder distinct from Kleefstra and Kabuki syndromes.
American journal of human genetics · 2024 · 29 citations · Joseph Shen
BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations.
European journal of human genetics : EJHG · 2025 · 17 citations · Daniah Beleford
Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results.
American journal of hematology · 2021 · 37 citations · Suma Shankar